UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2381925

2024

Volltextzugriff (PDF)

Correction to: Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

JNCI : Journal of the National Cancer Institute, 2024-08, Vol.116 (8), p.1407-1407

2024

Volltextzugriff (PDF)

Frontispiece: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Angewandte Chemie International Edition, 2024-09, Vol.63 (37), p.n/a

International ed. in English, 2024

Volltextzugriff (PDF)

Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol–Coated Biodegradable Nanoparticles

Journal of investigative dermatology, 2024-08

2024

Volltextzugriff (PDF)

Long-term storage and intradermal vaccination of tumor-derived exosomes via sugar microneedles for improving tumor immunotherapies

Chemical engineering journal (Lausanne, Switzerland : 1996), 2024-10, Vol.497, p.155595, Article 155595

2024

Volltextzugriff (PDF)

Galloyl-boosted gold nanorods: Unleashing personalized cancer immunotherapy potential

Journal of colloid and interface science, 2025-01, Vol.678 (Pt C), p.272-282

2025

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of novel HPK1 inhibitors possessing 3-cyano-quinoline moiety

Bioorganic chemistry, 2024-12, Vol.153, p.107814, Article 107814

2024

Volltextzugriff (PDF)

The effect of immunotherapy PD-1 blockade on acute bone cancer pain: Insights from transcriptomic and microbiomic profiling

International immunopharmacology, 2024-12, Vol.142 (Pt A), p.113100, Article 113100

2024

Volltextzugriff (PDF)

Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy

Molecular therapy, 2024-07

2024

Volltextzugriff (PDF)

Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy

Materials today (Kidlington, England), 2024-09, Vol.78, p.251-296

2024

Volltextzugriff (PDF)

VISTA: A promising target for overcoming immune evasion in gynecologic cancers

International immunopharmacology, 2024-09, Vol.138, p.112655, Article 112655

2024

Volltextzugriff (PDF)

The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy

Baillière's best practice & research. Clinical gastroenterology, 2024-08, p.101944, Article 101944

2024

Volltextzugriff (PDF)

MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors

Journal for immunotherapy of cancer, 2024-09, Vol.12 (9), p.e009600

2024

Volltextzugriff (PDF)

Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity

Frontiers in immunology, 2024-09, Vol.15, p.1455019

2024

Volltextzugriff (PDF)

Mechanistic conformational and substrate selectivity profiles emerging in the evolution of enzymes via parallel trajectories

Nature communications, 2024-08, Vol.15 (1), p.7068-17

2024

Volltextzugriff (PDF)

Immunomodulatory metal-based biomaterials for cancer immunotherapy

Journal of controlled release, 2024-11, Vol.375, p.249-268

2024

Volltextzugriff (PDF)

Design, synthesis, and antitumor activity evaluation of 1,2,3-triazole derivatives as potent PD-1/PD-L1 inhibitors

Bioorganic chemistry, 2024-12, Vol.153, p.107813, Article 107813

2024

Volltextzugriff (PDF)

Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy (Adv. Mater. 29/2024)

Advanced materials (Weinheim), 2024-07, Vol.36 (29), p.n/a

2024

Volltextzugriff (PDF)

T cell dysfunction and therapeutic intervention in cancer

Nature immunology, 2024-08, Vol.25 (8), p.1344-1354

2024

Volltextzugriff (PDF)

Disulfide bond-rich Nano-Silica for High-Efficiency cancer immunotherapy using synergistic endoplasmic reticulum stress cooperated mitochondrial dysfunction

Chemical engineering journal (Lausanne, Switzerland : 1996), 2024-10, Vol.498, p.154877, Article 154877

2024

Volltextzugriff (PDF)

Editorial: Developing biocompatible and biotechnological tools against cancer and autoimmune disorders

Frontiers in immunology, 2024-08, Vol.15, p.1466011

Ayaz, Furkan

2024

Volltextzugriff (PDF)

Frontispiz: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Angewandte Chemie, 2024-09, Vol.136 (37), p.n/a

2024

Volltextzugriff (PDF)

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Frontiers in immunology, 2024-07, Vol.15, p.1462081

2024

Volltextzugriff (PDF)

Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice

Nature communications, 2024-09, Vol.15 (1), p.8121-15

2024

Volltextzugriff (PDF)

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Nature reviews. Cancer, 2024-08, Vol.24 (8), p.523-539

2024

Volltextzugriff (PDF)

1 – 25 von 2.092

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.692)
Mit Volltextzugriff
(1.650)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(122)
Frontiers In Immunology
(74)
Journal For Immunotherapy Of Cancer
(74)
Bmc Cancer
(59)
Scientific Reports
(59)
Discover. Oncology
(50)
International Journal Of Molecular Sciences
(47)
Curēus
(34)
Cancer Medicine
(32)
Business Wire
(31)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(583)
... seit 7 Tagen
(29)

Menü

Weitere Dienste

Einstellungen

CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy

Correction to: Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

Frontispiece: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol–Coated Biodegradable Nanoparticles

Long-term storage and intradermal vaccination of tumor-derived exosomes via sugar microneedles for improving tumor immunotherapies

Galloyl-boosted gold nanorods: Unleashing personalized cancer immunotherapy potential

Design, synthesis, and biological evaluation of novel HPK1 inhibitors possessing 3-cyano-quinoline moiety

The effect of immunotherapy PD-1 blockade on acute bone cancer pain: Insights from transcriptomic and microbiomic profiling

Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy

Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy

VISTA: A promising target for overcoming immune evasion in gynecologic cancers

The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy

MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors

Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity

Mechanistic conformational and substrate selectivity profiles emerging in the evolution of enzymes via parallel trajectories

Immunomodulatory metal-based biomaterials for cancer immunotherapy

Design, synthesis, and antitumor activity evaluation of 1,2,3-triazole derivatives as potent PD-1/PD-L1 inhibitors

Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy (Adv. Mater. 29/2024)

T cell dysfunction and therapeutic intervention in cancer

Disulfide bond-rich Nano-Silica for High-Efficiency cancer immunotherapy using synergistic endoplasmic reticulum stress cooperated mitochondrial dysfunction

Editorial: Developing biocompatible and biotechnological tools against cancer and autoimmune disorders

Frontispiz: A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated Tumors

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Aktive Filter

Suchergebnisse filtern